Latest news with #JeffSorenson
Miami Herald
6 days ago
- Business
- Miami Herald
Yunu Unveils Next-Gen Trial Imaging with New eCRF Builder, Custom Dashboards & Universal Integration Portal
CARY, NC / ACCESS Newswire / May 29, 2025 / Yunu, the creator and leader in cloud-native imaging workflows for clinical trials, today announced a major new software release that empowers pharma sponsors to configure studies in minutes, enforce consistency, and deliver imaging data straight into their primary data systems - while simplifying work for site staff. Yunu's unified cloud-SaaS platform powers end-to-end imaging workflows for thousands of clinical trials worldwide. From de-identification and site assessments to blinded reads with adjudication and real-time data delivery to sponsors, Yunu harmonizes multi-site trials, reduces complexity, and accelerates timelines, thereby reducing costs for both sponsors and sites. Expanding these capabilities, Yunu's new eCRF builder, enhanced sponsor dashboards, and native integration portal deliver a new realm of possibilities for trial sponsors who have previously been limited to inefficient and expensive manual workflows, long timelines, and disconnected data. "To deliver better outcomes for patients, we have to be more protective of the imaging data that will define tomorrow's treatments," said Jeff Sorenson, CEO & Co-founder of Yunu. "With our new eCRF builder, intuitive dashboards, and seamless integration portal, sponsors gain full control over imaging endpoints - while sites benefit from a simpler, guided workflow and access to expert reading resources." KEY SPONSOR BENEFITS Rapid Customization of Imaging eCRFsProvides flexible capture of trial-specific data from directly within the QC and reading process, easily defined during the 30-minute study setup process, with no coding or Data, Custom Dashboards1,300+ standard data elements deliver unmatched context, traceability, and value with active monitoring of imaging schedules, scan availability, read status, and response rates across any combination of trials, therapeutic areas, participating sites, or Data IntegrationThe Yunu integration portal supports user-defined and configured APIs, allowing for easy integration between other eClinical and data systems and your Yunu imaging source of truth. Imaging eCRF outputs and all other captured data are sent directly from Yunu into your clinical data warehouse or EDC system in real time - eliminating manual handoffs and file transfers. SITE ADVANTAGES Guided, Error-Free WorkflowsRadiologists, whether onsite or remote, follow the same step-by-step process, delivering complete, standardized, harmonized, protocol-conformant imaging endpoints that eliminate cumbersome and error-prone manual paper forms or Read TurnaroundBy streamlining end-to-end imaging workflows and data management tasks, Yunu frees up site staff to focus on patient care rather than paperwork. All new features are available immediately to every Yunu customer and may be activated on any new or ongoing trial. Yunu will be exhibiting at the American Society of Clinical Oncology's (ASCO) Annual Meeting this weekend from Saturday, May 31st - Monday, June 2nd, at Booth #10080. Visit Yunu at ASCO or connect with the team by visiting ABOUT YUNUYunu enables life sciences organizations to streamline imaging workflows, improve accuracy, and accelerate timelines. Yunu's platform supports clinical trials across various therapeutic areas, offering scalability and flexibility for organizations of all sizes. For more information, visit and follow us on LinkedIn or X @Yunu_Inc.
Associated Press
16-04-2025
- Business
- Associated Press
Clinical Trials Imaging Innovator Yunu Raises Oversubscribed Funding Round Led by Spring Mountain Capital
Investment is aimed at accelerating Yunu's pharma sponsor and site network growth. CARY, NORTH CAROLINA / ACCESS Newswire / April 16, 2025 / Yunu, provider of transformative clinical trials imaging workflow solutions, secured an investment led by Spring Mountain Capital, affirming Yunu's position as an emerging category leader and proven innovator within the clinical trial imaging market. Yunu's platform delivers next-generation trial imaging workflow and ensures fast delivery of operational and clinical insights to sponsors. 'At Spring Mountain Capital, we look to invest in only the strongest teams that have built truly transformational healthcare software solutions. Yunu solves a primary challenge for trial sponsors who need to accelerate therapy development timelines and conduct more trials, in more places. With imaging becoming an increasing obstacle for everyone involved, we are proud to invest in Yunu and believe they are best positioned to solve these issues at scale and emerge as the new technology-forward industry leader,' said Jamie Weston, Managing Director. Imaging endpoints play a critical role in more than 90% of oncology trials, informing crucial efficacy and safety decisions. However, published data reveals that imaging error rates between 25-50% at leading cancer centers can add up to $5m in unnecessary costs and 200 days of avoidable delay in Phase II trials alone1. Yunu addresses this industry-wide accuracy crisis by serving as the source data system, reducing imaging errors, and delivering results to sponsors in real-time at a lower cost. Yunu eliminates repetitive manual tasks, geographic limitations, disparate software systems, and paper processes with a single, streamlined cloud software platform that makes information accessible to anyone, anywhere. 'At Yunu, we are driving end-to-end imaging workflows that offer unprecedented flexibility, accuracy, and value to sites and sponsors alike,' said Jeff Sorenson, Co-founder & CEO of Yunu. 'We are delighted to partner with Spring Mountain Capital on this next phase of growth and welcome Jamie Weston as the newest member of our board of directors.' Today, Yunu serves as the trial imaging platform across all oncology clinical trials at more than 25% of the NCI-designated Comprehensive Cancer Centers in America and manages over 5,000 active oncology trials sponsored by over 400 pharma companies. Yunu will be demonstrating its capabilities at upcoming industry meetings, including: About Yunu Yunu provides innovative imaging workflow and data management solutions designed to optimize clinical trial processes. By integrating advanced technologies, Yunu enables life sciences organizations to streamline imaging workflows, improve accuracy, and accelerate timelines. Yunu's platform supports clinical trials across various therapeutic areas, offering scalability and flexibility for organizations of all sizes. For more information, visit and follow us on LinkedIn or X @Yunu_Inc. Media Inquiries: [email protected] About Spring Mountain Capital Spring Mountain Capital is an investment management firm that focuses on alternative asset investing. The SMC Growth equity team focuses on providing expansion capital to companies capitalizing on breakthrough innovations, paradigm shifts, or fundamental market or behavioral changes. SMC invests in two sectors of the U.S. economy undergoing the most change and with the highest growth potential: enterprise technology and healthcare companies. For more information, visit Contact Information Lindsay Fleming Chief Marketing Officer [email protected] SOURCE: Yunu press release
